Navigation Links
New 2009 Cumulative Supplement to Pharmaceutical Patent Law Examines Critical Intersection Of Patent Law and Food And Drug Law
Date:10/14/2009

ARLINGTON, Va., Oct. 14 /PRNewswire-USNewswire/ -- The 2009 Cumulative Supplement to Pharmaceutical Patent Law delivers the latest legal developments in pharmaceutical patent law. Published by BNA Books, a division of BNA, Pharmaceutical Patent Law is supplemented annually and provides complete coverage of intricate topics, including the antitrust implications of patent settlements; the experimental use privilege; and international aspects of the field, including comparative data protection laws, the benefits and limitations of the Paris Convention, the Patent Cooperation Treaty, Foreign Filing Licenses, regional agreements, and the TRIPS agreement.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090529/DC24463LOGO )

The 2009 Cumulative Supplement includes the following new information:

  • Legislative developments in the 111th Congress concerning patents, follow-on biologics, and Hatch-Waxman reform
  • The continuing impact of Supreme Court precedent upon pharmaceutical patent law, including the law of obviousness and declaratory judgment jurisdiction
  • The new rules concerning the extension of the Hatch-Waxman Act's 30-month stay of marketing approval
  • Coverage of judicial reaction to concerns over baseless Paragraph IV ANDA filings
  • Updated information on the construction of pharmaceutical patent claims

Pharmaceutical Patent Law not only reviews current issues of importance, but identifies topics such as parallel importation and authorized generics that are likely to be of growing significance. The treatise is invaluable to the busy practitioner who must keep on track in this evolving area of the law. The author, Professor John R. Thomas, is a member of the faculty of Georgetown University Law Center, Washington, DC, where he teaches courses in both patent and food and drug law. A widely published author in the field of pharmaceutical patent law, he frequently serves as a Special Master in patent litigation before the federal courts.

BNA is a leading private publisher of news and information products for professionals in law and business. In addition to Pharmaceutical Patent Law, BNA's Book Division publishes Biotechnology and the Federal Circuit; Drafting Patent License Agreements; Electronic and Software Patents: Law and Practice; Intellectual Property Taxation: Transaction and Litigation Issues; International Patent Litigation: A Country-by-Country Analysis; Patent Infringement Remedies; Patent Law and Practice; Patent Prosecution: Law, Practice, and Procedure; Patent, Trademark, and Copyright Laws; Patent, Trademark, and Copyright Regulations; Patents and the Federal Circuit; Pharmaceutical Patent Law; Harmon on Patents: Black-Letter Law and Commentary; and other titles in legal specialties. The BNA Books website, including an online catalog, can be found at bnabooks.com.

The new 2009 Cumulative Supplement to Pharmaceutical Patent Law may be purchased alone (Order #1824-PRY9/$225.00 plus tax, shipping, and handling) or with the main volume (Order #9824-PRY9/$390.00 plus tax, shipping, and handling) from BNA Books, PO Box 7814, Edison, NJ 08818-7814. Telephone orders: 1-800-960-1220. Fax orders: 1-732-346-1624. For a free BNA Books catalog, call 1-800-960-1220 or send an e-mail request to books@bna.com. A 10% discount is available on print copies of books when ordered from the website at bnabooks.com. (Please note that discounts cannot be combined).

SOURCE BNA Books


'/>"/>
SOURCE BNA Books
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. PartnerRe Declares Dividends on Series C Cumulative Redeemable Preferred Shares and Series D Cumulative Redeemable Preferred Shares and Corrects Ex-Dividend Trading Date for Common Shares
2. Cumulative radiation exposure shows increased cancer risk for emergency department patients
3. EPA should pursue cumulative risk assessment of phthalates and other chemicals
4. Antioxidant Supplements May Raise Womens Skin Cancer Risk
5. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
6. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
7. Vitamin D Supplements May Lengthen Life
8. American Heart Association Surgical Supplement Journal Report: Appropriate Hospital Discharge System Can Prevent Future Cardiac Events
9. U of M study: Health food supplement may curb addiction of pathological gamblers
10. Joint Juice Launches New Ready-to-Drink Glucosamine & Vitamin-Enhanced Dietary Supplement Water Nationwide
11. Wellcorps International Unveils New Nutritional Supplements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... its strategic partnership with Connance, a healthcare industry leader providing predictive analytics ... proprietary technology combine to provide health systems, hospitals and ambulatory surgical centers ...
(Date:6/26/2016)... ... , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect ... a whole new perspective by using the title layers in ProSlice Levels to ... ProSlice Levels contains over 30 Different presets to choose from. FCPX users ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery ... of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , ... for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016 According to ... Type (Standard Pen Needles, Safety Pen Needles), Needle Length ... Growth Hormone), Mode of Purchase (Retail, Non-Retail) - Trends ... report studies the market for the forecast period of ... USD 2.81 Billion by 2021 from USD 1.65 Billion ...
(Date:6/23/2016)... , June 23, 2016 Research and ... Global Market - Forecast to 2022" report to their ... treatment method for the patients with kidney failure, it replaces ... fluid from the patient,s blood and thus the treatment helps ... and chloride in balance. Increasing number of ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... Analysis 2016 - Forecast to 2022" report to their ... contains up to date financial data derived from varied research ... trends with potential impact on the market during the next ... which comprises of sub markets, regional and country level analysis. ...
Breaking Medicine Technology: